Histone deacetylase inhibition by MS-275 potentiates glucose-stimulated insulin secretion without affecting glucose oxidation

This publication has 39 references indexed in Scilit:

• Acute exposure of beta-cells to troglitazone decreases insulin hypersecretion via activating AMPK
  Biochimica et Biophysica Acta (BBA) - General Subjects, 2014
• Metabolic Signaling in Fuel-Induced Insulin Secretion
  Cell Metabolism, 2013
• The future of epigenetic therapy in solid tumours—lessons from the past
  Nature Reviews Clinical Oncology, 2013
• A Novel High-Throughput Assay for Islet Respiration Reveals Uncoupling of Rodent and Human Islets
  PLOS ONE, 2012
• Type 2 diabetes as an inflammatory disease
  Nature Reviews Immunology, 2011
• A map of open chromatin in human pancreatic islets
  Nature Genetics, 2010
• An operational definition of epigenetics: Figure 1.
  Genes & Development, 2009
• Identification of small-molecule inducers of pancreatic β-cell expansion
  Proceedings of the National Academy of Sciences, 2009
• Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes
  Blood, 2008
• Specific targeting and constitutive association of histone deacetylase complexes during transcriptional repression
  Genes & Development, 2002